U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 851 - 860 of 13408 results

Status:
Investigational
Source:
INN:candocuronium iodide
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Candocuronium is bisquaternary aza steroid derivative with neuromuscular blocking, ganglion blocking, and vagolytic activities. Its potential adjunctive use in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation was briefly evaluated in clinical studies in India, but further development discontinued because of attendant cardiovascular effects, primarily tachycardia that was no worse than but also not an improvement over the clinically established pancuronium bromide.
Status:
Investigational
Source:
INN:orconazole
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Orconazole, an imidazole derivative, was developed by Janssen Pharmaceutical as an antifungal agent, however, this drug has never been marketed
Status:
Investigational
Source:
INN:rostafuroxin [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)



Rostafuroxin (PST 2238) is a digitoxygenin derivative, which selectively displaces ouabain from the Na ,K -ATPase receptor. PST 2238, at concentrations up to 10−4 M, did not show any significant interaction with a- and b-adrenergic, D1, D2, D3, 5-HT1, 5-HT2, H1, H2, M1, M2, A1, A2, Ca2 , Na , or K channel–associated receptors, AT1, AT2, ETa, ETb, GABA, thromboxane, vasopressin, angiotensin II, or the steorid-hormone receptors (androgen, progestogen, estrogen and mineralocorticoid), confirming that PST 2238 is specific for Na ,K -ATPase. Rostafuroxin has been developed in an attempt to unravel the contribution of mutated adducin and endogenous ouabain in the pathogenesis of hypertension. The compound lowered blood pressure in Milan hypertensive rats and humans. Rostafuroxine had been in phase II clinical trials for the treatment of hypertension. Following adverse events in Rostafuroxin group were described: dizziness, headache, upper respiratory tract infections, high blood pressure.
Status:
Investigational
Source:
USAN:LEVALBUTEROL SULFATE [USAN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
USAN:MECLORISONE DIBUTYRATE [USAN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
INN:mebolazine
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Mebolazine is an androgenic anabolic steroid.
Status:
Investigational
Source:
INN:mantabegron
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)


Mantabegron is an adamantane derivative with β3-adrenoreceptor agonist activity.
Status:
Investigational
Source:
INN:zoleprodolol [INN]
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Zoleprodolol was developed as an adrenoreceptor antagonist. Information about the current use of this compound is not available.
Status:
Investigational
Source:
INN:stevaladil
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Stevaladil is a pregnanediol derivative patented by Shionogi & Co., Ltd. as antiparasitic agent
Status:
Investigational
Source:
INN:ganglefene [INN]
Source URL:

Class (Stereo):
CHEMICAL (UNKNOWN)

Ganglefene is a coronary vasodilator. This n-cholinoblocker was originally studied for its effects on coronary circulation in angina pectoris. Animal studies have also shown shortened recovery period of motor functions after ganglefene administration. One rodent study showed that modulation of the n-cholinergic system by ganglefene in the developing fetal brain leads to changes in the quantitative and qualitative characteristics of elements of sexual behavior in pubescent offspring.